Inactive Instrument
Earth Science Tech, Inc. Stock Other OTC
Stocks
ETST
US2703111037
Pharmaceuticals
OTC Markets Traded| Market Cap | 30.14M 26.11M 24.47M 22.32M 41.95M 2.87B 42.6M 288M 112M 1.44B 113M 111M 4.8B | P/E 2027 * |
10.5x | P/E 2028 * | 10.5x |
|---|---|---|---|---|---|
| Enterprise Value | 30.14M 26.11M 24.47M 22.32M 41.95M 2.87B 42.6M 288M 112M 1.44B 113M 111M 4.8B | EV / Sales 2027 * |
0.72x | EV / Sales 2028 * | 0.69x |
| Free-Float |
33.37% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: Earth Science Tech, Inc.
| 1 day | -5.08% |
| Manager | Title | Age | Since |
|---|---|---|---|
Giorgio Saumat
CEO | Chief Executive Officer | 47 | 2023-02-12 |
Ernesto Flores
DFI | Director of Finance/CFO | 41 | 2024-03-03 |
Mario Tabraue
PSD | President | 47 | 2021-10-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mario Tabraue
BRD | Director/Board Member | 47 | 2021-10-31 |
Jeff Cazeau
BRD | Director/Board Member | 58 | 2023-02-12 |
Giorgio Saumat
CHM | Chairman | 47 | 2022-09-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.08% | -10.57% | - | - | 30.14M | ||
| +0.08% | +4.34% | +90.89% | +126.88% | 1,083B | ||
| +0.27% | +1.10% | +50.72% | +50.15% | 626B | ||
| -1.06% | +0.57% | +24.65% | +62.61% | 442B | ||
| -0.92% | +0.22% | +48.34% | +38.00% | 363B | ||
| -1.32% | -0.21% | +29.07% | +36.60% | 295B | ||
| -1.20% | -2.78% | +5.56% | +5.29% | 248B | ||
| +0.30% | +2.14% | +46.17% | +59.62% | 224B | ||
| -2.51% | +1.77% | -6.55% | -51.64% | 210B | ||
| +0.74% | +3.86% | +14.02% | +71.38% | 168B | ||
| Average | -1.11% | +2.88% | +33.65% | +44.32% | 406.57B | |
| Weighted average by Cap. | -0.47% | +4.29% | +49.17% | +64.75% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 42.04M 36.42M 34.13M 31.13M 58.52M 4.01B 59.42M 401M 157M 2.01B 158M 154M 6.69B | 43.98M 38.11M 35.7M 32.57M 61.23M 4.2B 62.17M 420M 164M 2.1B 165M 162M 7B |
| Net income | - | 3.85 3.34 3.13 2.85 5.36 367.21 5.44 36.76 14.37 183.87 14.46 14.14 613.1 |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals

















